Forest And Merz Announce FDA Approval Of Namenda XR For The Treatment Of Moderate To Severe Dementia Of The Alzheimer's Type

Links shared publicly online about this topic.

  • 1,073
    total visits

Forest And Merz Announce FDA Approval Of Namenda XR For The Treatment Of Moderate To Severe Dementia Of The Alzheimer's Type

medicalnewstoday.com

Forest Laboratories, Inc. (NYSE: FRX) and Merz Pharmaceuticals GmbH announced that Namenda XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment

View full resource at medicalnewstoday.com

Tags: Dementia, Alzheimer's Disease, Alzheimer's Disease Medication, Pharma, FDA, Namenda, Forest Laboratories

  • Share

Most Recently Shared on June 23, 2010 at 1:06 pm By:

mnt_drugapprov MNT Drug Approvals

Forest And Merz Announce FDA Approval Of Namenda XR For The Treatment Of Moderate To Severe Dementia Of The Alzheimer'... http://mnt.to/3Fdh

2 years ago...

Also Shared By:

MNT Alzheimer's News MNT Alzheimer's News

Forest and Merz Announce FDA Approval of Namenda XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

drugs.com — “Namenda XR (memantine) is used to treat Alzheimer's dementia. Includes Namenda XR side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 23, 2010 at 12:23 am By:

drugscom Drugs.com Health Site

FDA Approves Namenda XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type - http://bit.ly/a2g3Mj

2 years ago...

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

alzheimersreadingroom.com — “The Alzheimers Reading Room has clear, concise, usable news, research, insight and advice for the entire Alzheimers community. The website focuses on those suffering from Alzheimers disease and Dementia, Alzheimers caregivers, and the art of Alzheimers caregiving. 100 Million people have been touched by Alzheimers disease, and 35 million are worried about Alzheimers.View full resource at alzheimersreadingroom.com

  • View Related
  • Share

Most Recently Shared on June 22, 2010 at 7:22 pm By:

HCAVancouver Home Care Assistance Health Business

Forest and Merz announce FDA approval of NAMENDA XR for the treatment of moderate to severe dementia due to Alzheimer's http://bit.ly/clRWZf

2 years ago...

Advertisement